Indonesia Health Sector Review. Pharmaceuticals: Why reform is needed (Policy Note Series)
(2009; 11 pages)


Like other countries, Indonesia is attempting to improve health outcomes, provide financial protection from health care costs, and assure consumer satisfaction in a sustainable way through reforms and improvements in its health system.1 Medicines and vaccines have become an increasingly important input into effective health care services in the last 50 years. Essential medicines are a critical input to effective health services, and a major cost for the public sector and consumers. While spending on pharmaceuticals and vaccines is estimated to be around 30 percent of total health spending in Indonesia, there is overwhelming evidence that Indonesians are not getting good value for money from much of their spending on medicines. It is, therefore, important that the Government of Indonesia’s (GoI) medium-term development plan includes a focus on pharmaceuticals...

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017